MMP2 and ovarian carcinoma: As exhibited in the previous studies, decreased MMP-2 and MMP-9 expression has been shown to be associated with inhibited metastatic capacity in multiple human tumors, such as gastric cancer, colon cancer, ovarian cancer and HNSCC [30–32].